Chapter 8 An Assay System for In Vitro Detection of Permeability in Human "Endothelium"

Methods in Enzymology

Volumn 443, Issue , 2008, Pages 137-153

  Martins Green, Manuela ^a   Petreaca, Melissa ^b   Yao, Min ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Genomics and Bioinformatics   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; F ACTIN; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; INTERLEUKIN 8; MATRIGEL; PHALLOIDIN; RHODAMINE; VASCULOTROPIN; ACTIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR;

ANTIBODY LABELING; BASEMENT MEMBRANE; BLOOD VESSEL PERMEABILITY; CELL ASSAY; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; ENDOTHELIUM; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STAINING; ANIMAL; ARTICLE; CAPILLARY PERMEABILITY; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; METABOLISM; MOUSE; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ACTINS; ANIMALS; ANTIGENS, CD31; CAPILLARY PERMEABILITY; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; MICE; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 52049120787     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(08)02008-9     Document Type: Review

References (31)

1. Baldwin A.L., and Thurston G. Mechanics of endothelial cell architecture and vascular permeability. Crit. Rev. Biomed. Eng. 29 (2001) 247-278
2. Behzadian M.A., Windsor L.J., Ghaly N., Liou G., Tsai N.T., and Caldwell R.B. VEGF-induced paracellular permeability in cultured endothelial cells involves urokinase and its receptor. FASEB J. 17 (2003) 752-754
3. Bissell M.J., and Radisky D. Putting tumours in context. Nat. Rev. Cancer 1 (2001) 46-54
4. Breslin J.W., Pappas P.J., Cerveira J.J., Hobson II R.W., and Duran W.N. VEGF increases endothelial permeability by separate signaling pathways involving ERK-1/2 and nitric oxide. Am. J. Physiol. Heart Circ. Physiol. 284 (2003) H92-H100
5. Carmeliet P. Angiogenesis in health and disease. Nat. Med. 9 (2003) 653-660
6. Chandra A., Barillas S., Suliman A., and Angle N. A novel fluorescence-based cellular permeability assay. J. Biochem. Biophys. Methods 70 (2006) 329-333
7. Chen J., Somanath P.R., Razorenova O., Chen W.S., Hay N., Bornstein P., and Byzova T.V. Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat. Med. 11 (2005) 1188-1196
8. Chi J.T., Chang H.Y., Haraldsen G., Jahnsen F.L., Troyanskaya O.G., Chang D.S., Wang Z., Rockson S.G., van de Rijn M., Botstein D., and Brown P.O. Endothelial cell diversity revealed by global expression profiling. Proc. Natl. Acad. Sci. USA 100 (2003) 10623-10628
9. Conway E.M., Collen D., and Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc. Res. 49 (2001) 507-521
10. Culav E.M., Clark C.H., and Merrilees M.J. Connective tissues: Matrix composition and its relevance to physical therapy. Phys. Ther. 79 (1999) 308-319
11. Cullen V.C., Mackarel A.J., Hislip S.J., O'Connor C.M., and Keenan A.K. Investigation of vascular endothelial growth factor effects on pulmonary endothelial monolayer permeability and neutrophil transmigration. Gen. Pharmacol. 35 (2000) 149-157
12. Dvorak H.F., Brown L.F., Detmar M., and Dvorak A.M. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146 (1995) 1029-1039
13. Eliceiri B.P., Paul R., Schwartzberg P.L., Hood J.D., Leng J., and Cheresh D.A. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol. Cell 4 (1999) 915-924
14. Feistritzer C., Lenta R., and Riewald M. Protease-activated receptors-1 and -2 can mediate endothelial barrier protection: Role in factor Xa signaling. J. Thromb. Haemost. 3 (2005) 2798-2805
15. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 29 (2002) 15-18
16. Hashizume H., Baluk P., Morikawa S., McLean J.W., Thurston G., Roberge S., Jain R.K., and McDonald D.M. Openings between defective endothelial cells explain tumor vessel leakiness. Am. J. Pathol. 156 (2000) 1363-1380
17. Lal B.K., Varma S., Pappas P.J., Hobson II R.W., and Duran W.N. VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways. Microvasc. Res. 62 (2001) 252-262
18. Lee Y.C. The involvement of VEGF in endothelial permeability: A target for anti-inflammatory therapy. Curr. Opin. Invest. Drugs 6 (2005) 1124-1130
19. Miller D.W., Keller B.T., and Borchardt R.T. Identification and distribution of insulin receptors on cultured bovine brain microvessel endothelial cells: Possible function in insulin processing in the blood brain barrier. J. Cell Physiol. 161 (1994) 333-341
20. Miura S., Matsuo Y., and Saku K. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells. Hypertension 41 (2003) 1118-1123
21. Nobe K., Sone T., Paul R.J., and Honda K. Thrombin-induced force development in vascular endothelial cells: Contribution to alteration of permeability mediated by calcium-dependent and -independent pathways. J. Pharmacol. Sci. 99 (2005) 252-263
22. Petreaca M.L., Yao M., Liu Y., Defea K., and Martins-Green M. Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability. Mol. Biol. Cell 18 (2007) 5014-5023 Epub Oct 10. 2007
23. Pettersson A., Nagy J.A., Brown L.F., Sundberg C., Morgan E., Jungles S., Carter R., Krieger J.E., Manseau E.J., Harvey V.S., Eckelhoefer I.A., Feng D., Dvorak A.M., Mulligan R.C., and Dvorak H.F. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab. Invest. 80 (2000) 99-115
24. Seye C.I., Yu N., Gonzalez F.A., Erb L., and Weisman G.A. The P2Y2 nucleotide receptor mediates vascular cell adhesion molecule-1 expression through interaction with VEGF receptor-2 (KDR/Flk-1). J. Biol. Chem. 279 (2004) 35679-35686
25. Stolz D.B., Bannish G., and Jacobson B.S. The role of the cytoskeleton and intercellular junctions in the transcellular membrane protein polarity of bovine aortic endothelial cells in vitro. J. Cell Sci. 103 (1992) 53-68
26. Sun H., Breslin J.W., Zhu J., Yuan S.Y., and Wu M.H. Rho and ROCK signaling in VEGF-induced microvascular endothelial hyperpermeability. Microcirculation 13 (2006) 237-247
27. Tanimoto T., Jin Z.G., and Berk B.C. Transactivation of vascular endothelial growth factor (VEGF) receptor Flk-1/KDR is involved in sphingosine 1-phosphatestimulated phosphorylation of Akt and endothelial nitric-oxide synthase (eNOS). J. Biol. Chem. 277 (2002) 42997-43001
28. Thuringer D., Maulon L., and Frelin C. Rapid transactivation of the vascular endothelial growth factor receptor KDR/Flk-1 by the bradykinin B2 receptor contributes to endothelial nitric-oxide synthase activation in cardiac capillary endothelial cells. J. Biol. Chem. 277 (2002) 2028-2032
29. Thurston G., Suri C., Smith K., McClain J., Sato T.N., Yancopoulos G.D., and McDonald D.M. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286 (1999) 2511-2514
30. Varma S., Breslin J.W., Lal B.K., Pappas P.J., Hobson II R.W., and Duran W.N. p42/44MAPK regulates baseline permeability and cGMP-induced hyperpermeability in endothelial cells. Microvasc. Res. 63 (2002) 172-178
31. Weis S.M., and Cheresh D.A. Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437 (2005) 497-504